Rani Therapeutics Holdings Income Statement (2020-2025) | RANI

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.06M0.11M0.21M0.76M1.96M-1.21M-1.27M-1.32M-1.30M1.03M0.17M
Operating items
Research & Development 2.56M2.09M3.34M3.35M3.76M11.96M7.42M7.59M9.53M9.10M10.39M9.71M11.09M11.22M7.61M7.59M6.12M6.17M6.81M6.57M5.50M3.22M
Selling, General & Administrative 0.89M0.84M1.82M2.61M3.46M15.82M5.95M6.19M6.32M7.24M7.10M6.80M7.21M6.63M5.83M6.45M6.41M5.63M5.46M5.62M5.00M4.04M
Other Operating Expenses -34.01M3.71M
Operating Expenses 3.45M2.94M-28.86M5.95M7.22M27.78M13.36M13.78M15.85M16.34M17.48M16.52M18.29M17.86M13.43M14.03M12.52M11.80M15.99M12.19M10.51M7.26M
Operating Income -3.39M-2.83M-4.94M-5.20M-5.26M-27.78M-13.36M-13.78M-15.85M-16.34M-17.48M-16.52M-18.29M-17.86M-13.43M-14.03M-12.52M-11.80M-14.96M-12.01M-10.51M-7.26M
EBIT -3.39M-2.83M-4.94M-5.20M-5.26M-27.78M-13.36M-13.78M-15.85M-16.34M-17.48M-16.52M-18.29M-17.86M-13.43M-14.03M-12.52M-11.80M-14.96M-12.01M-10.51M-7.26M
Non-operating items
Interest & Investment Income 0.01M0.01M-0.02M0.05M0.01M0.01M0.02M0.01M0.04M0.38M0.82M0.89M0.90M0.84M0.68M0.55M0.44M0.41M0.36M0.22M0.16M0.07M
Other Non Operating Income -0.70M1.40M
Net income details
EBT -2.71M-2.88M-5.74M-5.55M-5.48M-28.66M-13.35M-13.77M-15.81M-16.32M-17.38M-16.83M-18.66M-18.33M-14.05M-14.78M-13.36M-12.72M-15.72M-12.74M-11.22M-7.91M
Tax Provisions 0.01M0.01M0.01M0.04M0.00M0.04M-0.04M0.06M0.15M-0.11M-0.01M
Profit After Tax -2.71M-2.88M-5.76M-5.60M-5.49M-28.70M-13.30M-13.83M-15.97M-16.21M-17.34M-16.83M-18.66M-18.33M-14.05M-14.78M-13.36M-12.72M-15.74M-12.74M-11.22M-7.91M
Income from Non-Controlling Interests -2.88M-5.76M-5.60M-5.49M-25.56M-8.12M-7.61M-8.34M-8.25M-8.56M-8.46M-9.36M-9.13M-6.96M-7.30M-6.56M-5.94M-6.78M-5.47M-4.53M-2.50M
Income from Continuing Operations -2.71M-2.88M-5.76M-5.60M-5.49M-28.70M-13.30M-13.83M-15.97M-16.21M-17.37M-16.83M-18.66M-18.33M-14.05M-14.78M-13.36M-12.72M-15.72M-12.74M-11.22M-7.91M
Consolidated Net Income -2.71M-2.88M-5.76M-5.60M-5.49M-28.70M-13.30M-13.83M-15.97M-16.21M-17.37M-16.83M-18.66M-18.33M-14.05M-14.78M-13.36M-12.72M-15.72M-12.74M-11.22M-7.91M
Income towards Parent Company -2.71M-2.88M-5.76M-5.60M-5.49M-28.70M-13.30M-13.83M-15.97M-16.21M-17.37M-16.83M-18.66M-18.33M-14.05M-14.78M-13.36M-12.72M-15.72M-12.74M-11.22M-7.91M
Net Income towards Common Stockholders -2.71M-2.88M-5.76M-5.60M-5.49M-28.70M-13.30M-13.83M-15.97M-16.21M-17.37M-16.83M-18.66M-18.33M-14.05M-14.78M-13.36M-12.72M-15.72M-12.74M-11.22M-7.91M
Additional items
EPS (Basic) -0.06-0.12-0.16-0.270.290.310.33-2.21-0.33-0.37-0.36-0.27-0.29-0.26-0.24-552.11-0.22-0.18-0.12
EPS (Weighted Average and Diluted) -0.16-0.270.290.310.33-2.21-0.33-0.37-0.36-0.27-0.29-0.26-0.24-552.11-0.22-0.18-0.12
Shares Outstanding (Weighted Average) 46.89M46.90M19.44M0.02M21.41M24.37M24.47M0.02M25.24M25.34M25.55M0.03M26.03M26.32M28.84M0.03M33.44M36.54M46.44M
Shares Outstanding (Diluted Average) 19.44M0.02M21.41M24.37M24.47M0.02M25.24M25.34M25.55M0.03M26.03M26.32M28.84M0.03M33.44M36.54M46.44M
EBITDA -3.39M-2.83M-4.94M-5.20M-5.26M-27.78M-13.36M-13.78M-15.85M-16.34M-17.48M-16.52M-18.29M-17.86M-13.43M-14.03M-12.52M-11.80M-14.96M-12.01M-10.51M-7.26M
Interest Expenses 0.00M0.06M0.06M0.19M0.17M0.11M-0.00M0.35M0.72M1.21M1.27M1.32M1.30M1.29M1.28M1.34M1.12M0.94M0.88M0.72M
Shares Outstanding 46.89M46.89M46.89M46.90M46.90M
Tax Rate -0.22-0.17-0.21-0.77-0.02-0.130.30-0.46-0.970.650.06